14 /100
LOW RISK
Score updated Jul 14, 2026

BXP — BXP, Inc. Dilution Risk Tracker

Track BXP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BXP — Get alerts when the score changes →

As of July 14, 2026, BXP, Inc. (BXP) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. BXP, Inc. has a market capitalization of $10.70B, 159.48M shares outstanding, 548 institutional holders tracked. Key dilution vectors include ATM program capacity of $1.00B, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
25
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $1000M remaining capacity
🔁 Convertible Conversion 15%
• Convertible debt present: 5.3% potential dilution
🔔 Track BXP — Get forecast alerts →

💹 Market Data

Market Cap$10.70B
Shares Outstanding159.48M
Float147.83M
Cash$512.78M
Debt$3.30B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 18.5% shares (2026Q1 vs prior)
548 institutional holders · 219.86M shares
#1 COHEN & STEERS, INC. 20.85M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 19.94M shares
#3 First Eagle Investment Management, LLC 18.69M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest11.33M
Days to Cover6.7
% of Float7.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Apr 01, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BXP Shareholders

BXP, Inc. (BXP) has a DilutionScore of 14/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

BXP has an active ATM (at-the-market) program with $1.00B remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for BXP in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BXP alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track BXP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BXP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BXP
📊 BXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BXP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.